Comparison of Deferiprone to Deferasirox and Deferoxamine to Cardiac and Hepatic T2* MRI in Thalassemia Patients: Evidence-based Case Report

• Главные авторы: Pustika Amalia Wahidiyat (Автор), Mikhael Yosia (Автор), Teny Tjitra Sari (Автор)
• Формат: ‌
• Опубликовано: Interna Publishing, 2018-06-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: there are currently three iron chelator readily available for patients Indonesia; deferiprone/DFP (branded as Ferriprox), deferasirox/DFX (branded as Exjade) and deferoxamine/DFO (branded as Desferal). This study aims to determine which iron chelator is the most efficient in reducing car...